\
&
Contact us
\
&
Contact us
This was 2 years ago
LocationOnline
ProgrammesNet4Society, the NCP network for Cluster 2, will organize a virtual information and matchmaking event in cooperation with the European Commission on the Cluster 2 Call “European Collaborative Cloud for Cultural Heritage (ECCCH)”.
This event will consist of two main sessions:
- The morning session contains the presentation on the ECCCH topics proposed for 2023 under the Work Programme 2023-2024 of Horizon Europe Cluster 2 with subsequent questions & answers.
- The afternoon session is all about networking! During the Matchmaking activities, applicants will have the opportunity to meet and connect with others, identify possible partners to facilitate the forming of strong project consortia and share ideas and brainstorm potential projects.
For more information please visit the event websites:
European Commission: Events | The research and innovation community platform (europa.eu)
Matchmaking event website: European Collaborative Cloud for Cultural Heritage Information and Matchmaking event - Info (b2match.io)
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
